pdufa.bio
Home › Condition › Infectious Disease & Vaccines

Upcoming Infectious Disease & Vaccines FDA decisions & readouts

Updated ยทnext FDA decision on the calendar
PDUFA target dates and trial readouts in infectious disease & vaccines, each linked to its primary source. Updated from FDA/SEC/ClinicalTrials.gov; dates can shift.
Cancer & OncologyObesity & MetabolicCNS & NeurologyImmunology & InflammationCardiovascularRare DiseaseHematologyOphthalmology & Eye

Trial readouts (24)

IVVD · Aug 2026 (est.)
VYD2311: COVID-19
MIRM · Aug 2026 (est.)
Brelovitug: Chronic Hepatitis D Infection
BIVI · Aug 2026 (est.)
NE3107: Long COVID
AVIR · Sep 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
TRAW · Nov 2026 (est.)
rigosertib: Influenza
VIR · Nov 2026 (est.)
Bulevirtide: Viral Hepatitis
EVO · Nov 2026 (est.)
JST-018: Antiviral Drug
ENTA · Dec 2026 (est.)
Zelicapavir: RSV Infection
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
TRAW · Dec 2026 (est.)
rigosertib: Influenza
VIR · Dec 2026 (est.)
Tobevibart: Viral Hepatitis
ABUS · Dec 2026 (est.)
AB-729: Chronic Hepatitis B
VIR · Dec 2026 (est.)
Tobevibart: Viral Hepatitis
NBP · 2026-H1
TJ003234: Coronavirus Disease 2019 COVID-19
PCVX · 2026-H2
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
PCVX · Jan 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
PCVX · Mar 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
ALGS · Mar 2027 (est.)
ALG-000184: Chronic Hepatitis B Infection
MIRM · Jun 2027 (est.)
BJT-778: Chronic Hepatitis D Infection
MIRM · Aug 2027 (est.)
Brelovitug: Chronic Hepatitis D
ACXP · Sep 2027 (est.)
Ibezapolstat: Clostridium Difficile Infection Recurrence
MRK · Oct 2027 (est.)
MK-8527: Human Immunodeficiency Virus (HIV)
ANTX · Dec 2027 (est.)
Epetraborole: Mycobacterium Abscessus Infection
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
We don't show an approval percentage for these infectious disease & vaccines catalysts. Here's why.